Cardiac Neurodevelopmental Outcome Collaborative is ranked #2 of 9 disease & disorders organizations in Richmond, VA, with an America's Best Score of 77 out of 100, based on its 2025 Form 990.
Cardiac Neurodevelopmental Outcome Collaborative is a 501(c)(3) organization, classified under Disease & Disorders (NTEE G43). Contributions are tax-deductible.
2209 Dickens Rd, Richmond, VA 23230-2005
Among the 10 scored disease & disorders organizations in Richmond, Cardiac Neurodevelopmental Outcome Collaborative holds 43.6 months of operating reserves (peer median 10 months), runs a typical yearly surplus of 72.1% (peers: surplus of 2.8%), and has cut spending 7.6% a year (peers: grown spending 9.1% a year).
In fiscal year 2025 it reported $319,183 in revenue and $202,446 in expenses, with contributions making up 0.0% of revenue.
The cnoc is a not-for-profit organization established to determine and implement best practices of neurodevelopmental and psychosocial services for individuals with pediatric and congenital heart disease and their families through clinical, quality improvement, and research initiatives.
Largest programs · fiscal year 2025
Provide training, education, and relevant information to members through publications, the annual symposium, and the website and to foster community outreach through these same forums.$167,970 spent · 100.0% of program spending
Cnoc's neurodevelopmental core lab (ndc) and data analysis core (dac) are researching the development of infants, toddlers and preschoolers who have undergone neonatal cardiac surgery using a limited list of demographic, neurodevelopmental, medical history and surgical variables. As initial aims are achieved, neurodevelopmental testing outcomes, quality of life outcomes and medical history data wi… Read more
Cnoc's neurodevelopmental core lab (ndc) and data analysis core (dac) are researching the development of infants, toddlers and preschoolers who have undergone neonatal cardiac surgery using a limited list of demographic, neurodevelopmental, medical history and surgical variables. As initial aims are achieved, neurodevelopmental testing outcomes, quality of life outcomes and medical history data will be added to these efforts.
The purpose of the cnoc investigator award is to provide funding support for cnoc members to leverage the cnoc infrastructure to conduct research and/or quality improvement science aimed at improving neurodevelopmental, psychosocial outcomes, and/or quality of life for children and families affected by congenital heart disease (chd).
Where each dollar went · fiscal year 2025
Of every dollar it spent, 83¢ went to programs, 17¢ to management and 0¢ to fundraising.
Programs $167,970
Management $34,476
Fundraising $0
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Spending on programs Not scored; America's Best needs 65%+
83%
Meets
Compared with Richmond peers
Measure
This organization
Peer median
Operating reserves
43.6 mo
10.0 mo
Typical margin
+72.1%
+2.8%
Spending growth
−7.6% / yr
+9.1% / yr
Debt load
10.0%
5.9%
Peers: the 10 Richmond disease & disorders organizations with a score, ranked or below the bar.
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$319,183Fiscal year 2025
Expenses$202,446Fiscal year 2025
Total assets$816,043Fiscal year 2025
Total liabilities$81,227Fiscal year 2025
Fiscal year ending December2025
Revenue$319,183
Expenses$202,446
Net income$116,737
Net assets$734,816
Notable sources of revenue
Percent of total revenue
Contributions
$0
0.0%
Program services
$302,470
94.8%
Investment income
$16,713
5.2%
Other (net)
$0
0.0%
Assets / debt
Total assets
$816,043
Total liabilities
$81,227
Net assets
$734,816
Compensation
Not in our extract for this year.
Fiscal year ending December2024
Revenue$322,742
Expenses$173,063
Net income$149,679
Net assets$591,752
Notable sources of revenue
Percent of total revenue
Contributions
$0
0.0%
Program services
$307,360
95.2%
Investment income
$15,382
4.8%
Other (net)
$0
0.0%
Assets / debt
Total assets
$655,327
Total liabilities
$63,575
Net assets
$591,752
Compensation
Not in our extract for this year.
Fiscal year ending December2023
Revenue$208,879
Expenses$98,798
Net income$110,081
Net assets$433,543
Notable sources of revenue
Percent of total revenue
Contributions
$0
0.0%
Program services
$204,300
97.8%
Investment income
$4,579
2.2%
Other (net)
$0
0.0%
Assets / debt
Total assets
$485,511
Total liabilities
$51,968
Net assets
$433,543
Compensation
Not in our extract for this year.
Fiscal year ending December2022
Revenue$297,250
Expenses$256,758
Net income$40,492
Net assets$319,776
Notable sources of revenue
Percent of total revenue
Contributions
$0
0.0%
Program services
$297,250
100.0%
Investment income
$0
0.0%
Other (net)
$0
0.0%
Assets / debt
Total assets
$426,180
Total liabilities
$106,404
Net assets
$319,776
Compensation
Officers and key employees
$0
Share of expenses
0.0%
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?